NCT02752386

Brief Summary

The purpose of this study is to test whether a novel form of biofeedback training can help individuals regulate their pain more effectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 27, 2016

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
Last Updated

September 26, 2019

Status Verified

September 1, 2019

Enrollment Period

2.4 years

First QC Date

April 19, 2016

Last Update Submit

September 24, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in nociceptive flexion reflex threshold

    physiological marker of pain processing

    Assessed at the beginning and end of each of the 3 biofeedback training days

  • Change in temporal summation of pain

    marker of pain facilitation (change in pain rating 0-100 that occurs in response to a mechanical stimulus series)

    Assessed at the beginning and end of each of the 3 biofeedback training days

Study Arms (3)

Biofeedback Training 1

EXPERIMENTAL

Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction. Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback. Electric stimulations will be delivered throughout the biofeedback to provide pain relief when relaxation is achieved.

Behavioral: Biofeedback Training

Biofeedback Training 2

ACTIVE COMPARATOR

Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction. Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback. Electric stimulations will be delivered throughout the biofeedback to provide a painful context in which to practice relaxing.

Behavioral: Biofeedback Training

Biofeedback Training 3

ACTIVE COMPARATOR

Participants will receive brief training in relaxation and biofeedback to develop basic skills in relaxation/arousal reduction. Then they will receive instructions to relax and reduce arousal as they view graphical arousal feedback.

Behavioral: Biofeedback Training

Interventions

Participants will received biofeedback training to reduce arousal and pain

Biofeedback Training 1Biofeedback Training 2Biofeedback Training 3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy pain free individuals over the age of 18.

You may not qualify if:

  • under 18 years of age (given the nature of the study)
  • history of serious cardiovascular, neuroendocrine, or neurological disorders
  • hypertension (due to a relationship between blood pressure and pain);5 4) history of chronic pain
  • current opioid, antidepressant, or anxiolytic medication use
  • psychosis or apparent cognitive impairment
  • body mass index\>35 (due to difficulty eliciting an NFR in persons with high adiposity)
  • inability to understand and read English (questionnaires and consent form are in English)
  • recent use of an over-the-counter pain medication (within the last 24 hours) or narcotic medication (within the last two weeks)
  • history of panic attacks. No one will be excluded based on ethnic, racial, or gender characteristics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Tulsa

Tulsa, Oklahoma, 74104, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jamie L Rhudy, PhD

    The University of Tulsa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 19, 2016

First Posted

April 27, 2016

Study Start

February 1, 2016

Primary Completion

July 1, 2018

Study Completion

July 31, 2018

Last Updated

September 26, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations